These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25529014)

  • 41. Working memory in schizotypal personality disorder: fMRI activation and deactivation differences.
    Vu MA; Thermenos HW; Terry DP; Wolfe DJ; Voglmaier MM; Niznikiewicz MA; McCarley RW; Seidman LJ; Dickey CC
    Schizophr Res; 2013 Dec; 151(1-3):113-23. PubMed ID: 24161536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.
    Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB
    Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in working memory networks in amnestic mild cognitive impairment.
    Migo EM; Mitterschiffthaler M; O'Daly O; Dawson GR; Dourish CT; Craig KJ; Simmons A; Wilcock GK; McCulloch E; Jackson SH; Kopelman MD; Williams SC; Morris RG
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2015; 22(1):106-27. PubMed ID: 24617815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neural correlates during working memory processing in major depressive disorder.
    Wang XL; Du MY; Chen TL; Chen ZQ; Huang XQ; Luo Y; Zhao YJ; Kumar P; Gong QY
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():101-8. PubMed ID: 25174680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.
    Conroy SK; McDonald BC; Smith DJ; Moser LR; West JD; Kamendulis LM; Klaunig JE; Champion VL; Unverzagt FW; Saykin AJ
    Breast Cancer Res Treat; 2013 Jan; 137(2):493-502. PubMed ID: 23263697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Family Functioning Mediates the Association Between Neurocognitive Functioning and Health-Related Quality of Life in Young Adult Survivors of Childhood Brain Tumors.
    Hocking MC; Hobbie WL; Deatrick JA; Hardie TL; Barakat LP
    J Adolesc Young Adult Oncol; 2015 Mar; 4(1):18-25. PubMed ID: 25852971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Effects of Bushen Capsule on Episodic Memory in Amnestic Mild Cognitive Impairment Patients: A Pilot Placebo Controlled fMRI Study.
    Zhang J; Xu K; Wei D; Guo R; Li H; Wang Y; Zhang Z
    J Alzheimers Dis; 2015; 46(3):665-76. PubMed ID: 25854932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A functional MRI investigation of the association between childhood aerobic fitness and neurocognitive control.
    Chaddock L; Erickson KI; Prakash RS; Voss MW; VanPatter M; Pontifex MB; Hillman CH; Kramer AF
    Biol Psychol; 2012 Jan; 89(1):260-8. PubMed ID: 22061423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.
    Deprez S; Vandenbulcke M; Peeters R; Emsell L; Smeets A; Christiaens MR; Amant F; Sunaert S
    J Clin Oncol; 2014 Jul; 32(19):2031-8. PubMed ID: 24868029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy.
    Kreukels BPC; Hamburger HL; de Ruiter MB; van Dam FSAM; Ridderinkhof KR; Boogerd W; Schagen SB
    Clin Neurophysiol; 2008 Mar; 119(3):533-541. PubMed ID: 18164658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer.
    Amidi A; Christensen S; Mehlsen M; Jensen AB; Pedersen AD; Zachariae R
    Br J Cancer; 2015 Sep; 113(5):794-801. PubMed ID: 26171932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
    Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
    J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy.
    Stouten-Kemperman MM; de Ruiter MB; Caan MW; Boogerd W; Kerst MJ; Reneman L; Schagen SB
    Hum Brain Mapp; 2015 Nov; 36(11):4638-47. PubMed ID: 26304182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.
    Pernin V; Belin L; Cottu P; Bontemps P; Lemanski C; De La Lande B; Baumann P; Missohou F; Levy C; Peignaux K; Reynaud-Bougnoux A; Denis F; Gobillion A; Bollet M; Vago NA; Dendale R; Campana F; Fourquet A; Kirova YM
    Br J Radiol; 2015 Apr; 88(1048):20140800. PubMed ID: 25645108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.
    Phillips KM; Jim HS; Small BJ; Laronga C; Andrykowski MA; Jacobsen PB
    Cancer; 2012 Apr; 118(7):1925-32. PubMed ID: 22161750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.